Zenotech Laboratories Reports Strong Sales Growth Amid Mixed Financial Performance in March 2025

Zenotech Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The company has experienced a notable adjustment in its evaluation, with its score shifting to -2 from -5 over the past three months.
The financial results reveal several positive developments for Zenotech Laboratories. The net sales for the quarter reached Rs 12.13 crore, marking the highest figure in the last five quarters and reflecting a growth of 21.2% compared to the average net sales of the previous four quarters. Additionally, the operating profit also reached a peak at Rs 4.47 crore, with an operating profit margin of 36.85%, indicating improved efficiency. Furthermore, the profit before tax stood at Rs 2.75 crore, the highest in the last five quarters, suggesting a favorable near-term trend.

Conversely, the company faced challenges as well. The profit after tax for the latest six months was recorded at Rs 2.60 crore, showing a year-on-year decline of 35.26%. Additionally, the debtors turnover ratio was at its lowest in the last five half-yearly periods, indicating a slowdown in the pace of settling debts.

For more insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.